A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies

NCT00569179 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Leukemia, Myeloid, Acute
Leukemia, Lymphoid
Myelodysplastic Syndromes
Leukemia, Myelogenous, Chronic

Interventions

DEVICE: CliniMACS CD34 Reagent System

Sponsor

Indiana University